Literature DB >> 12837711

Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial.

T Bruce Ferguson1, Eric D Peterson, Laura P Coombs, Mary C Eiken, Meghan L Carey, Frederick L Grover, Elizabeth R DeLong.   

Abstract

CONTEXT: A rigorous evaluation of continuous quality improvement (CQI) in medical practice has not been carried out on a national scale.
OBJECTIVE: To test whether low-intensity CQI interventions can be used to speed the national adoption of 2 coronary artery bypass graft (CABG) surgery process-of-care measures: preoperative beta-blockade therapy and internal mammary artery (IMA) grafting in patients 75 years or older. DESIGN, SETTING, AND PARTICIPANTS: Three hundred fifty-nine academic and nonacademic hospitals (treating 267 917 patients using CABG surgery) participating in the Society of Thoracic Surgeons National Cardiac Database between January 2000 and July 2002 were randomized to a control arm or to 1 of 2 groups that used CQI interventions designed to increase use of the process-of-care measures. INTERVENTION: Each intervention group received measure-specific information, including a call to action to a physician leader; educational products; and periodic longitudinal, nationally benchmarked, site-specific feedback. MAIN OUTCOME MEASURE: Differential incorporation of the targeted care processes into practice at the intervention sites vs the control sites, assessed by measuring preintervention (January-December 2000)/postintervention (January 2001-July 2002) site differences and by using a hierarchical patient-level analysis.
RESULTS: From January 2000 to July 2002, use of both process measures increased nationally (beta-blockade, 60.0%-65.6%; IMA grafting, 76.2%-82.8%). Use of beta-blockade increased significantly more at beta-blockade intervention sites (7.3% [SD, 12.8%]) vs control sites (3.6% [SD, 11.5%]) in the preintervention/postintervention (P =.04) and hierarchical analyses (P<.001). Use of IMA grafting also tended to increase at IMA intervention sites (8.7% [SD, 17.5%]) vs control sites (5.4% [SD,15.8%]) (P =.20 and P =.11 for preintervention/postintervention and hierarchical analyses, respectively). Both interventions tended to have more impact at lower-volume CABG sites (for interaction: P =.04 for beta-blockade; P =.02 for IMA grafting).
CONCLUSIONS: A multifaceted, physician-led, low-intensity CQI effort can improve the adoption of care processes into national practice within the context of a medical specialty society infrastructure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837711     DOI: 10.1001/jama.290.1.49

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  28 in total

1.  The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery.

Authors:  Marko Simunovic; Angela Coates; Charles H Goldsmith; Lehana Thabane; Dana Reeson; Andrew Smith; Robin S McLeod; Franco DeNardi; Timothy J Whelan; Mark N Levine
Journal:  CMAJ       Date:  2010-08-09       Impact factor: 8.262

2.  Quality improvement implementation and hospital performance on quality indicators.

Authors:  Bryan J Weiner; Jeffrey A Alexander; Stephen M Shortell; Laurence C Baker; Mark Becker; Jeffrey J Geppert
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

3.  The 61st Annual Scientific Meeting of The Japanese Association for Thoracic Surgery Fukuoka, October 12-15, 2008. Editorial.

Authors:  Shinichi Takamoto; Hiroaki Miyata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-12-11

Review 4.  Global implementation of genomic medicine: We are not alone.

Authors:  Teri A Manolio; Marc Abramowicz; Fahd Al-Mulla; Warwick Anderson; Rudi Balling; Adam C Berger; Steven Bleyl; Aravinda Chakravarti; Wasun Chantratita; Rex L Chisholm; Vajira H W Dissanayake; Michael Dunn; Victor J Dzau; Bok-Ghee Han; Tim Hubbard; Anne Kolbe; Bruce Korf; Michiaki Kubo; Paul Lasko; Erkki Leego; Surakameth Mahasirimongkol; Partha P Majumdar; Gert Matthijs; Howard L McLeod; Andres Metspalu; Pierre Meulien; Satoru Miyano; Yaakov Naparstek; P Pearl O'Rourke; George P Patrinos; Heidi L Rehm; Mary V Relling; Gad Rennert; Laura Lyman Rodriguez; Dan M Roden; Alan R Shuldiner; Sukdeb Sinha; Patrick Tan; Mats Ulfendahl; Robyn Ward; Marc S Williams; John E L Wong; Eric D Green; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2015-06-03       Impact factor: 17.956

Review 5.  Surgical ethics: today and tomorrow.

Authors:  Robert M Sade; Minoo N Kavarana
Journal:  Future Cardiol       Date:  2017-10-20

6.  Power of the Cluster.

Authors:  Michael S Lauer; George A Mensah
Journal:  Circulation       Date:  2015-07-17       Impact factor: 29.690

7.  Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.

Authors:  Judson B Williams; Elizabeth R Delong; Eric D Peterson; Rachel S Dokholyan; Fang-Shu Ou; T Bruce Ferguson
Journal:  Circulation       Date:  2010-12-20       Impact factor: 29.690

8.  The economic burden of complications during percutaneous coronary intervention.

Authors:  Kurt M Jacobson; Kirsten Hall Long; Erin K McMurtry; James M Naessens; Charanjit S Rihal
Journal:  Qual Saf Health Care       Date:  2007-04

9.  Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?

Authors:  Charles A Herzog; Jeremy W Strief; Allan J Collins; David T Gilbertson
Journal:  Nephrol Dial Transplant       Date:  2008-02-25       Impact factor: 5.992

10.  Accelerating best care at baylor dallas.

Authors:  Ziad Haydar; Marsha Cox; Pam Stafford; Vera Rodriguez; David J Ballard
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.